119 related articles for article (PubMed ID: 70771)
41. KCl carcinoma extracts as tumor antigens in the electrophoretic mobility test: clinical evaluation.
Muhrer KH; Link KH
Cancer Detect Prev; 1983; 6(1-2):101-6. PubMed ID: 6883371
[TBL] [Abstract][Full Text] [Related]
42. Leucocyte migration inhibition test in patients with gynaecologic malignancy.
Tosner J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(4):415-89. PubMed ID: 6978511
[No Abstract] [Full Text] [Related]
43. [The effect of the concentration and origin of antigens on leukocyte migration in women with malignant gynecologic tumors].
Tosner J; Fixa B
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(2):121-7. PubMed ID: 6969923
[No Abstract] [Full Text] [Related]
44. [Importance of CA-50 detection in malignant gynecologic tumors].
Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
[TBL] [Abstract][Full Text] [Related]
45. [Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors].
Suzuki M; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
Rinsho Byori; 1989 Jul; 37(7):784-8. PubMed ID: 2558243
[TBL] [Abstract][Full Text] [Related]
46. [Gynecologic examinations in paraplegics].
Schneeweiss WD
Wien Med Wochenschr; 1984 Nov; 134(22):495-8. PubMed ID: 6531934
[TBL] [Abstract][Full Text] [Related]
47. Variations of plasma CEA levels in gynecologic malignancies: incidence, significance and changes occurring in response to therapy.
Lecca U; Marcello C; Medda F; Mattana C; Manca P; Fodde M; Caminiti F
Eur J Gynaecol Oncol; 1980 Dec; 1(3):150-7. PubMed ID: 7341264
[TBL] [Abstract][Full Text] [Related]
48. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
[TBL] [Abstract][Full Text] [Related]
49. Lymphocyte supernatants and the electrophoretic mobility of erythrocytes: further experience of cancer diagnosis.
Dyson JE; Watkinson AP; Jones WG; Corbett PJ; Joslin CA
Br J Cancer; 1980 Sep; 42(3):448-54. PubMed ID: 7000116
[TBL] [Abstract][Full Text] [Related]
50. Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long-term followup of female genital cancer.
Khoo SK; Mackay EV
Cancer; 1974 Sep; 34(3):542-8. PubMed ID: 4850874
[No Abstract] [Full Text] [Related]
51. A contribution to immunological tumour diagnostics in urology.
Günther M; Friedrich A; Erdmann T; Jenssen HL; Werner H; Seyfarth M; Köhler H
Int Urol Nephrol; 1978; 10(2):111-5. PubMed ID: 81191
[TBL] [Abstract][Full Text] [Related]
52. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
Glaves D; Harlos JP; Weiss L
Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
[TBL] [Abstract][Full Text] [Related]
53. [Experiences with the electrophoretic mobility test in children. A diagnostic help in pediatric oncology? (author's transl)].
Ritter J; Oehme J
Monatsschr Kinderheilkd (1902); 1978 Sep; 126(9):556-60. PubMed ID: 80743
[TBL] [Abstract][Full Text] [Related]
54. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
55. [Monitoring of malignant gynecologic tumors using the immune response to lactate dehydrogenase virus antigens].
Freitag P; Jandová A; Macků J; Bendová M; Nedbalová M
Ceska Gynekol; 1994 Oct; 59(5):264-7. PubMed ID: 7804568
[TBL] [Abstract][Full Text] [Related]
56. Urine excretion of tumor-associated antigens by patients with gynecologic neoplasms.
Rote NS; Smith WG; Johnson GH
Gynecol Oncol; 1980 Jun; 9(3):370-5. PubMed ID: 6991377
[No Abstract] [Full Text] [Related]
57. Serum copper, zinc levels, and copper. Zinc ratio in healthy women and women with gynecological tumors.
Cetinkaya N; Cetinkaya D; Yüce M
Biol Trace Elem Res; 1988 Dec; 18():29-38. PubMed ID: 2484566
[TBL] [Abstract][Full Text] [Related]
58. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
Nitzschke U; Zwergel T; Lampert F
Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
[TBL] [Abstract][Full Text] [Related]
59. [Electrophoretic mobility of lymphocytes in multiple myeloma and bronchial cancer].
Ricci C; Cascio G; Alemanno L; Anania A; Gallarate G; Omedè P; Valente E
Minerva Med; 1979 Sep; 70(42):2855-61. PubMed ID: 386169
[TBL] [Abstract][Full Text] [Related]
60. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons].
Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M
Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
